Entries by Paola Zamora

, ,

Establishment Labs Statement in Response to TGA’s Breast Implant Review related to Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

July 15, 2019 Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on women’s health in breast surgery. Women are at the center of everything we do at Establishment Labs and it is our mission to protect their health by offering safe solutions in breast aesthetics and reconstruction. Based on those […]

,

Breast Implant Safety: What You Need to Know About Shell Surface Type

Motiva SmoothSilk®   With the continuing news coverage of breast implant-related events, many of us – especially those with breast implants of our own – may be left feeling concerned about the potential risks of having or receiving such devices, and even confused by the often highly technical terms being used in media coverage. Education […]

Establishment Labs Statement in Response to ANSM Decision to Ban Macrotextured and Polyurethane Breast Implants in France

April 4, 2019 Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on women’s health in breast surgery. Women are at the center of everything we do at Establishment Labs and it is our mission to protect their health by offering safe solutions in breast aesthetics and reconstruction. Based on those […]